#BEGIN_DRUGCARD DB07588

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C22H15N3O4

# Chemical_IUPAC_Name:
3,4-bis(1H-indol-3-yl)-1H-pyrrole-2,5-dicarboxylic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2010-09-15 15:23:55 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
3,4-DI-1H-INDOL-3-YL-1H-PYRROLE-2,5-DICARBOXYLIC ACID

# HET_ID:
CRR

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C22H15N3O4/c26-21(27)19-17(13-9-23-15-7-3-1-5-11(13)15)18(20(25-19)22(28)29)14-10-24-16-8-4-2-6-12(14)16/h1-10,23-25H,(H,26,27)(H,28,29)

# InChI_Key:
InChIKey=FZDVNXHYGMEEDT-UHFFFAOYSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
7594

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
385.3722

# Molecular_Weight_Mono:
385.106255983

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
Not Available

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
3.9

# Predicted_LogS:
-5.2

# Predicted_Water_Solubility:
2.52e-03 g/l

# Primary_Accession_No:
DB07588

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
11326613

# PubChem_Substance_ID:
99444059

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
Not Available

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
OC(=O)C1=C(C2=CNC3=CC=CC=C23)C(=C(N1)C(O)=O)C1=CNC2=C1C=CC=C2

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:25:49 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_1_Essentiality:
Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
AB088119

# Drug_Target_1_GenBank_ID_Protein:
27753571

# Drug_Target_1_GeneCard_ID:
staP

# Drug_Target_1_Gene_Name:
staP

# Drug_Target_1_Gene_Sequence:
>2832 bp
ATGAGGGAGAAAATGCACAGCTGTTCACGGTCGGCAATGGCAAAGTGCGAGAATCCGGTT
CTCAACGCAGTTCACACACAGCCCATTTCCCGGGGAGCAGTGCACGGCAGGGAAGACCAA
CTGGCCCAGACGATCACGCAGCTGCGCGCCGTGGCGAGCAGCGGGCGGAGCACGGTGCTG
GTGCTGGGGGCGGTTCCCGGCGCCGGCAAGACCCGGCTCCTCAGGGAGGCGGCGTCGCTC
GCCGAGAGCGACGGCTTCATGGTGCTGAGCGCCGCCCCGGCCGGGCCCGACACCACCCCC
GAGGCCGTCATCGAGGCGGCGCGGACACGGCTCCCCGGCGCCGGGAGCACCCGCACCACC
GTCGTCCTCGACGATCTGCATCTGGCGGGACTCCCCGCACTGACGACGCTGAACGACCTC
GTCGTGGCCCTCAGGGGACGTCCGATCCTCTGGCTGCTCGCCTTCACCACGGAACGCGAC
GCCCCACCCCCGGAACACCTGCGGGCCTCTCTCGGCGGACTCCGCGCCAGCCTCCCGGTG
GAGCACATGCGGGAGCTGGGACCGATCGAGGGCGACGCGCTGGCACAGTTGGTCGCCGAC
CACACCGGAGCCACCCCCGACCCGGCTCTCCTCGCCCTCGCGGAGAGCGTCAACGCCACG
CCGCGCTCGGTGATCGAGTTGATTCGCGGCCTGGCGGAGGACGACGACCTGTGCCTGATC
GACGGCACCACCCGATTACAGCCCGGCCCACCCGGCGACCCCTCGGCCGGGTGGGGCGTC
CCGGTGCCCACCCCCGTACCGAAACGGTTCTCCGCGACCGTCCAGCAAGACCTCAGGACA
CTGTCGGACCCCACCCTGAAGGCGCTCAGACTGGCCGCCGTCCTCGGATCACCGTTCGCA
CCGGAAGACCTGTCGGCCCTGCTCGACGAAGCACCCGTCGGTCTGCTCGCCGCCGTGGAC
GAGGCCGTCGACCGGGGCCTGCTCGTCTGCGGCGAACGCGACCTCGCCTTCCGCACCGAG
CCGATCTGGCGGGTCCTGCTCGACTCCGTACCGCCCCCGGTGCTCGCCCTGCTGCGCCGG
CAGGCCGCGAAGATCGTGCTGCCGCGCCCCGACGGCGTCGAGCGCGCCGCCCTCCAACTG
GTCCACGTCGCCCAACCCGGCAACACGGACGAACTGCGCATCATCGCCGAGGGCTCCCGC
AGACTCCTGCTCGCCGACCCGTCCGCAGCCGCCTCGCTCGCCACCCGCTCCATGGAGTTC
CTGGACCCCGGCACCGCCGAGCGGGTGCGACTGGCACGGACCGCCGTCGAAGCGCTCACC
AGAGCCGGCCGACTGGACCACGCGATCGCCCTGGCCAAGGACACCGTCGACGAGACAGCC
CGCCTCGCCGCCCCACTGCCGCCGGAGCTCGTCGAGGACGTCGCCGCGTTGCGGGCCTCG
ATGTCGACCGCCCTGCTGCTCCTCGGCGACGCCCGCCTCGCCCGCCGAGCGGCAGGCGAC
GCGCTCGCGGTACAGCACGGCGGGCCCCAGCACCGCGAGGCGGTCGTCGCCCACCTCGCC
GCCTCCTACCTCACCGGCGACGCCAGCGCCGCCCAGCGCGCACGCCAGATCCTCGGCGCA
CCCGACCGCCACACCGGCGCCGTGCAGGTGGGCGCGATGACCTTCCACGCCTTCGGCCAG
TGGCGCGCCGGCGACGTCGGCGAGGCCGTGGCCACCCTGCGCAGGGCGGTCGCCCTCGAC
CGCGCCGACGACGAGGCGCCGATCCTCGACCCCCGCTGGTTCCTCACCTTCACCCTCGCC
AGGACCGACGAGTACGAGCAGGCGGCGGCCGTCATCCGGAGCTCCGCCGCCATCGCCTCG
AAACACGGCACGCTGACCACCGCGGTCCCCGCCGTGCTCCGCGCCCAACTGAACCTCGCA
CAGGGCCGGTTGGACGAGGCGGAGGACGACGCCAAGCTCGGGGTCGGCACCGACGGCCCC
TTTGTGCCGATGCTCGCCCCGCAGGCATGGCTGGTTCTAGCCTCCGTGGCCCTGCGCCGA
GGAGCGCTCGCCCAGGCCGAGGAACACATCAAGACCCTGGAGAAGGACTTCCCCCAGCAC
GCCTCCAGCCCCTGGTGGGGCGCGCGGCTGCTGCTCAACGCGCAGTTGGCCGAGGCACAG
GCCGACCAGCACGCCGCGACGGAGGTGCTGGCCGAGATCGGGGCGCAGAACGGTGCGCTC
CGCGAGGTCGTCCTGGAGGATCCGGCCGCGGCGGCCTGGTGGGTACGGTGCGCTCTCGCG
GCCGAGCGACCCGACCTCGTCTCGACGGTGATCGAGGCGACGGAGCACCTCCGTGGACGC
AACCAGTGCGTGCCCTCGGTGGTGGCCATGGCCATGCACGCCCGGGCGCTCGCCGAAGGG
GACGCCGAGGCACTCGACCGGGCCGGGCGGCTACACCGCAATCCCTGGGCGCAGGCGACC
GCGGCCGAGGACCACGCGGGGCTGCTCCTCGACCGTGGGGAGCACGAGGCCGCCATCGGT
GAGTTCGACCGGGCGATGAGCGCCTTCGGCGCGCTCGGCGGGGAGCGGGACGCCGCCCGG
GTGCGGGCGCGGCTGCGTGCGCTGGGGGTACGGCGGCGGCACTGGACGCATGCGAAACGT
CCGGTGTCCGGGTGGGAGAGCCTGACCAAGACCGAGCGGAAGGTGGCCGAGCTGGTGGCC
GGGGGGCTCACCAATCAGCAGGCCGCCCGGCATCTGTTCATCTCACCGCACACGGTCGGG
TTCCATCTGCGCCAGATCTACCGGAAGTTGGGCATCCGGTCGCGCACCGCGCTGATTCGG
CTGAGGGCGTGA

# Drug_Target_1_General_Function:
Secondary metabolites biosynthesis, transport and catabolism

# Drug_Target_1_General_References:
12617516	Onaka H, Taniguchi S, Igarashi Y, Furumai T: Cloning of the staurosporine biosynthetic gene cluster from Streptomyces sp. TP-A0274 and its heterologous expression in Streptomyces lividans. J Antibiot (Tokyo). 2002 Dec;55(12):1063-71.
16195595	Onaka H, Asamizu S, Igarashi Y, Yoshida R, Furumai T: Cytochrome P450 homolog is responsible for C-N bond formation between aglycone and deoxysugar in the staurosporine biosynthesis of Streptomyces sp. TP-A0274. Biosci Biotechnol Biochem. 2005 Sep;69(9):1753-9.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
6262

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
46125.6

# Drug_Target_1_Name:
Cytochrome P450

# Drug_Target_1_Number_of_Residues:
417

# Drug_Target_1_PDB_ID:
Not Available

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00067	p450

# Drug_Target_1_Protein_Sequence:
>Cytochrome P450
MASATLPRFDLMGWDKKDIADPYPVYRRYREAAPVHRTASGPGKPDTYYVFTYDDVVRVL
SNRRLGRNARVASGDTDTAPVPIPTEHRALRTVVENWLVFLDPPHHTELRSLLTTEFSPS
IVTGLRPRIAELASALLDRLRAQRRPDLVEGFAAPLPILVISALLGIPEEDHTWLRANAV
ALQEASTTRARDGRGYARAEAASQEFTRYFRREVDRRGGDDRDDLLTLLVRARDTGSPLS
VDGIVGTCVHLLTAGHETTTNFLAKAVLTLRAHRDVLDELRTTPESTPAAVEELMRYDPP
VQAVTRWAYEDIRLGDHDIPRGSRVVALLGSANRDPARFPDPDVLDVHRAAERQVGFGLG
IHYCLGATLARAEAEIGLRALLDGIPALGRGAHEVEYADDMVFHGPTRLLLDLPDAA

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Not Available

# Drug_Target_1_SwissProt_ID:
Q83WG3

# Drug_Target_1_SwissProt_Name:
Q83WG3_9ACTO

# Drug_Target_1_Synonyms:
Not Available

# Drug_Target_1_Theoretical_pI:
6.33

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB07588
